CSTM
Constellium SE [CSTM] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CSTM Stock Summary
Top 10 Correlated ETFs
CSTM
Top 10 Correlated Stocks
CSTM
In the News
CSTM Financial details
CSTM Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 43.16 | 35.2 | 43.63 | 56.54 | 48.56 | |
| Net income per share | 0.43 | -0.12 | 1.82 | 2.1 | 0.86 | |
| Operating cash flow per share | 3.27 | 2.41 | 2.53 | 3.14 | 3.39 | |
| Free cash flow per share | 1.29 | 1.1 | 0.89 | 1.24 | 1.13 | |
| Cash per share | 1.51 | 3.45 | 1.45 | 1.37 | 1.59 | |
| Book value per share | -0.7 | -0.83 | 1.94 | 5.09 | 5.77 | |
| Tangible book value per share | -4.46 | -4.17 | -1.55 | 1.53 | 2.43 | |
| Share holders equity per share | -0.7 | -0.83 | 1.94 | 5.09 | 5.77 | |
| Interest debt per share | 18.53 | 18.38 | 16.28 | 15.23 | 12.61 | |
| Market cap | 1.63B | 1.59B | 2.23B | 1.59B | 2.64B | |
| Enterprise value | 3.81B | 3.54B | 4.21B | 3.48B | 4.31B | |
| P/E ratio | 27.62 | -93.39 | 8.68 | 5.29 | 21.11 | |
| Price to sales ratio | 0.28 | 0.33 | 0.36 | 0.2 | 0.37 | |
| POCF ratio | 3.65 | 4.75 | 6.25 | 3.53 | 5.32 | |
| PFCF ratio | 9.26 | 10.45 | 17.84 | 8.95 | 15.94 | |
| P/B Ratio | -16.97 | -13.81 | 8.14 | 2.18 | 3.13 | |
| PTB ratio | -16.97 | -13.81 | 8.14 | 2.18 | 3.13 | |
| EV to sales | 0.64 | 0.72 | 0.68 | 0.43 | 0.61 | |
| Enterprise value over EBITDA | 7.36 | 9.22 | 5.61 | 5.61 | 6.7 | |
| EV to operating cash flow | 8.52 | 10.6 | 11.8 | 7.72 | 8.69 | |
| EV to free cash flow | 21.63 | 23.29 | 33.69 | 19.56 | 26.01 | |
| Earnings yield | 0.04 | -0.01 | 0.12 | 0.19 | 0.05 | |
| Free cash flow yield | 0.11 | 0.1 | 0.06 | 0.11 | 0.06 | |
| Debt to equity | -24.59 | -20.79 | 7.77 | 2.81 | 2.03 | |
| Debt to assets | 0.56 | 0.58 | 0.46 | 0.42 | 0.37 | |
| Net debt to EBITDA | 4.21 | 5.08 | 2.64 | 3.04 | 2.59 | |
| Current ratio | 1.06 | 1.35 | 1.13 | 1.21 | 1.31 | |
| Interest coverage | 1.46 | 0.79 | 2.9 | 2.55 | 2.78 | |
| Income quality | 6.98 | -19.65 | 1.36 | 1.46 | 4.05 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.05 | 0.05 | 0.04 | 0.03 | 0.04 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.13 | 0.12 | 0.11 | 0.11 | 0.11 | |
| Capex to operating cash flow | -0.61 | -0.54 | -0.65 | -0.61 | -0.67 | |
| Capex to revenue | -0.05 | -0.04 | -0.04 | -0.03 | -0.05 | |
| Capex to depreciation | -1.06 | -0.7 | -0.87 | -0.95 | -1.15 | |
| Stock based compensation to revenue | -0.03 | -0.01 | -0.02 | 0 | -0.07 | |
| Graham number | 2.61 | 1.51 | 8.93 | 15.49 | 10.54 | |
| ROIC | 0.09 | 0.03 | 0.15 | 0.17 | 0.09 | |
| Return on tangible assets | 0.02 | 0 | 0.06 | 0.07 | 0.03 | |
| Graham Net | -24.64 | -22.75 | -21.92 | -20.38 | -18.18 | |
| Working capital | 78M | 380M | 224M | 363M | 432.36M | |
| Tangible asset value | -610M | -579M | -218M | 220M | 355.71M | |
| Net current asset value | -2.92B | -2.76B | -2.4B | -2.13B | -1.98B | |
| Invested capital | -24.59 | -20.79 | 7.77 | 2.81 | 2.03 | |
| Average receivables | 530.5M | 440M | 544.5M | 611M | 510.7M | |
| Average payables | 983.5M | 952M | 1.14B | 1.42B | 1.2B | |
| Average inventory | 665M | 626M | 816M | 1.19B | 1.21B | |
| Days sales outstanding | 29.29 | 30.35 | 40.52 | 24.23 | 24.81 | |
| Days payables outstanding | 68.73 | 75.19 | 91.58 | 71.89 | 53.05 | |
| Days of inventory on hand | 46.1 | 48.36 | 69.83 | 64.69 | 62.57 | |
| Receivables turnover | 12.46 | 12.03 | 9.01 | 15.06 | 14.71 | |
| Payables turnover | 5.31 | 4.85 | 3.99 | 5.08 | 6.88 | |
| Inventory turnover | 7.92 | 7.55 | 5.23 | 5.64 | 5.83 | |
| ROE | -0.61 | 0.15 | 0.94 | 0.41 | 0.15 | |
| Capex per share | -1.98 | -1.31 | -1.65 | -1.9 | -2.26 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 12.78 | 13.55 | 13.31 | 11.72 | 10.7 | |
| Net income per share | 0.19 | 0.14 | 0.21 | 0.44 | 0.07 | |
| Operating cash flow per share | 0.89 | 0.24 | 0.91 | 1.05 | 1.2 | |
| Free cash flow per share | 0.13 | -0.24 | 0.46 | 0.53 | 0.38 | |
| Cash per share | 1.37 | 1.54 | 1.08 | 1.31 | 1.58 | |
| Book value per share | 5.07 | 5.16 | 5.36 | 6.06 | 5.75 | |
| Tangible book value per share | 1.52 | 1.7 | 1.95 | 2.58 | 2.42 | |
| Share holders equity per share | 5.07 | 5.16 | 5.36 | 6.06 | 5.75 | |
| Interest debt per share | 14.48 | 14.79 | 14.04 | 13.25 | 11.92 | |
| Market cap | 1.6B | 2.02B | 2.32B | 2.55B | 2.65B | |
| Enterprise value | 3.49B | 3.93B | 4.19B | 4.3B | 4.32B | |
| P/E ratio | 14.29 | 25.28 | 18.7 | 9.96 | 66.28 | |
| Price to sales ratio | 0.87 | 1.03 | 1.19 | 1.48 | 1.69 | |
| POCF ratio | 12.5 | 59.47 | 17.44 | 16.56 | 15.01 | |
| PFCF ratio | 84.21 | -57.77 | 34.11 | 32.69 | 47.98 | |
| P/B Ratio | 2.19 | 2.72 | 2.95 | 2.87 | 3.14 | |
| PTB ratio | 2.19 | 2.72 | 2.95 | 2.87 | 3.14 | |
| EV to sales | 1.89 | 2.01 | 2.15 | 2.5 | 2.75 | |
| Enterprise value over EBITDA | 25.29 | 29.31 | 22.64 | 22.05 | 28.6 | |
| EV to operating cash flow | 27.27 | 115.53 | 31.5 | 27.92 | 24.45 | |
| EV to free cash flow | 183.69 | -112.23 | 61.61 | 55.12 | 78.15 | |
| Earnings yield | 0.02 | 0.01 | 0.01 | 0.03 | 0 | |
| Free cash flow yield | 0.01 | -0.02 | 0.03 | 0.03 | 0.02 | |
| Debt to equity | 2.81 | 2.82 | 2.58 | 2.15 | 2.03 | |
| Debt to assets | 0.42 | 0.42 | 0.41 | 0.4 | 0.37 | |
| Net debt to EBITDA | 13.7 | 14.22 | 10.11 | 8.97 | 11.04 | |
| Current ratio | 1.21 | 1.21 | 1.22 | 1.32 | 1.31 | |
| Interest coverage | 1.82 | 1.77 | 2.63 | 3.28 | 2.34 | |
| Income quality | 4.27 | 1.55 | 4.16 | 2.41 | 18.13 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.11 | 0.1 | 0.11 | 0.11 | 0.11 | |
| Capex to operating cash flow | -0.85 | -2.03 | -0.49 | -0.49 | -0.69 | |
| Capex to revenue | -0.06 | -0.04 | -0.03 | -0.04 | -0.08 | |
| Capex to depreciation | -1.4 | -0.96 | -0.9 | -0.99 | -1.71 | |
| Stock based compensation to revenue | 0 | 0 | 0 | -0.06 | -0.03 | |
| Graham number | 4.7 | 4.01 | 5.05 | 7.71 | 2.97 | |
| ROIC | 0.02 | 0.02 | 0.02 | 0.03 | 0.01 | |
| Return on tangible assets | 0.01 | 0 | 0.01 | 0.02 | 0 | |
| Graham Net | -20.29 | -19.8 | -19.45 | -17.99 | -18.1 | |
| Working capital | 363M | 378M | 396M | 482M | 432.36M | |
| Tangible asset value | 220M | 245M | 286M | 379M | 355.71M | |
| Net current asset value | -2.13B | -2.05B | -1.98B | -1.91B | -1.98B | |
| Invested capital | 2.81 | 2.82 | 2.58 | 2.15 | 2.03 | |
| Average receivables | 680.5M | 654.5M | 758.5M | 694.5M | 562.2M | |
| Average payables | 1.58B | 1.51B | 1.34B | 1.24B | 1.14B | |
| Average inventory | 1.35B | 1.27B | 1.19B | 1.14B | 1.12B | |
| Days sales outstanding | 26.31 | 35.43 | 34.48 | 33.59 | 27.62 | |
| Days payables outstanding | 76.01 | 77.42 | 58.7 | 78.02 | 59.98 | |
| Days of inventory on hand | 68.39 | 61.62 | 59.53 | 65.51 | 70.74 | |
| Receivables turnover | 3.42 | 2.54 | 2.61 | 2.68 | 3.26 | |
| Payables turnover | 1.18 | 1.16 | 1.53 | 1.15 | 1.5 | |
| Inventory turnover | 1.32 | 1.46 | 1.51 | 1.37 | 1.27 | |
| ROE | 0.04 | 0.03 | 0.04 | 0.07 | 0.01 | |
| Capex per share | -0.76 | -0.48 | -0.44 | -0.52 | -0.83 |
CSTM Frequently Asked Questions
What is Constellium SE stock symbol ?
Constellium SE is a FR stock and trading under the symbol CSTM
What is Constellium SE stock quote today ?
Constellium SE stock price is $20.665 today.
Is Constellium SE stock public?
Yes, Constellium SE is a publicly traded company.
Company Profile
- Volume Average 696.91K
- Market Capitalization 3.05B
- Employee 11.1K
- CEO Mr. Jean-Marc Germain
- Headquarters Paris,FR
- IPO Date 2013-05-23
-
Website
https://www.constellium.com 
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of specialty rolled and extruded aluminum products for the packaging, aerospace, and automotive end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry. The Packaging & Automotive Rolled Products segment produces rolled aluminum products, including can stock and closure stock for the beverage and food industry, as well as foil stock for the flexible packaging market. It also supplies automotive body sheets and heat exchangers for the automotive market; and specialty reflective sheets. The Aerospace & Transportation segment provides rolled aluminum products, including aerospace plates, sheets, and extrusions; and aerospace wing skins, as well as plates and sheets for use in transportation, industry, and defense applications. The Automotive Structures & Industry segment offers extruded products and technologically advanced structures for the automotive industry, including crash-management systems, body structures, side impact beams, and battery enclosures; and hard and soft alloy extruded profiles for various industry applications in the automotive, engineering, rail, and other transportation end markets. This segment also provides downstream technology and services, which include pre-machining, surface treatment, research and development, and technical support services. The company sells its products directly or through distributors in France, Germany, the Czech Republic, the United Kingdom, Switzerland, and the United States, as well as Shanghai, and Seoul. Constellium SE was incorporated in 2010 and is headquartered in Paris, France.
